Prokinetic · Laxative
A selective serotonin 5HT4-receptor agonist with prokinetic properties.
Increased plasma concentrations of prucalopride, potentially leading to an increased incidence or severity of prucalopride-related adverse effects (e.g., headache, nausea, diarrhea, abdominal pain).
Monitor for increased adverse effects of prucalopride. A dose reduction of prucalopride may be considered if adverse effects become bothersome or severe, especially in patients with renal impairment.
Source: DDInter
Increased plasma concentrations of prucalopride, potentially leading to an increased incidence or severity of prucalopride-related adverse effects (e.g., headache, nausea, diarrhea, abdominal pain).
Monitor for increased adverse effects of prucalopride. A dose reduction of prucalopride may be considered if adverse effects become bothersome or severe, especially in patients with renal impairment.
Source: DDInter
Increased plasma concentrations of prucalopride, potentially leading to an increased incidence or severity of prucalopride-related adverse effects (e.g., headache, nausea, diarrhea, abdominal pain).
Monitor for increased adverse effects of prucalopride. A dose reduction of prucalopride may be considered if adverse effects become bothersome or severe, especially in patients with renal impairment.
Source: DDInter
Increased plasma concentrations of prucalopride, potentially leading to an increased incidence or severity of prucalopride-related adverse effects (e.g., headache, nausea, diarrhea, abdominal pain).
Monitor for increased adverse effects of prucalopride. A dose reduction of prucalopride may be considered if adverse effects become bothersome or severe, especially in patients with renal impairment.
Source: DDInter
Increased plasma concentrations of prucalopride, potentially leading to an increased incidence or severity of prucalopride-related adverse effects (e.g., headache, nausea, diarrhea, abdominal pain).
Monitor for increased adverse effects of prucalopride. A dose reduction of prucalopride may be considered if adverse effects become bothersome or severe, especially in patients with renal impairment.
Source: DDInter
Increased plasma concentrations of prucalopride, potentially leading to an increased incidence or severity of prucalopride-related adverse effects (e.g., headache, nausea, diarrhea, abdominal pain).
Monitor for increased adverse effects of prucalopride. A dose reduction of prucalopride may be considered if adverse effects become bothersome or severe, especially in patients with renal impairment.
Source: DDInter
6 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e, Katzung, BNF·Updated: 2026-05-10